BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38504436)

  • 1. Clinical Efficacy and Gut Microbiota Regulating-Related Effect of Si-Jun-Zi Decoction in Postoperative Non-Small Cell Lung Cancer Patients: A Prospective Observational Study.
    He Y; Qi A; Gu Y; Zhang C; Wang Y; Yang W; Bi L; Gong Y; Jiao L; Xu L
    Integr Cancer Ther; 2024; 23():15347354241237973. PubMed ID: 38504436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginseng-Containing Sijunzi Decoction Ameliorates Ulcerative Colitis by Orchestrating Gut Homeostasis in Microbial Modulation and Intestinal Barrier Integrity.
    Wu Y; Zheng Y; Wang X; Tang P; Guo W; Ma H; Zhang A; Li D; Xie Y; Wang CZ; Yao H; Wan JY; Yuan CS
    Am J Chin Med; 2023; 51(3):677-699. PubMed ID: 36883990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of polysaccharide and nonpolysaccharide components in Sijunzi decoction on spleen deficiency syndrome and their mechanisms.
    Ma P; Peng Y; Zhao L; Liu F; Li X
    Phytomedicine; 2021 Dec; 93():153790. PubMed ID: 34710756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Dai L; Liu Z; Zhou W; Zhang L; Miao M; Wang L; Hua H; Wang B; Ji G
    Phytomedicine; 2024 Apr; 129():155636. PubMed ID: 38640860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sulfur-fumigated ginseng on the global quality of Si-Jun-Zi decoction, a traditional ginseng-containing multi-herb prescription, evaluated by metabolomics and glycomics strategies.
    Liu H; Wang SY; Zhu JH; Xu JD; Zhou SS; Kong M; Mao Q; Li SL; Zhu H
    J Pharm Biomed Anal; 2022 Sep; 219():114927. PubMed ID: 35816772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocultivation of Chinese prescription and intestine microbiota: SJZD alleviated the major symptoms of IBS-D subjects by tuning neurotransmitter metabolism.
    Xia X; Xie Y; Chen Q; Ding D; Wang Z; Xu Y; Wang Y; Wang X; Ding W
    Front Endocrinol (Lausanne); 2022; 13():1053103. PubMed ID: 36452327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics integrated analyses indicated that non-polysaccharides of Sijunzi decoction ameliorated spleen deficiency syndrome via regulating microbiota-gut-metabolites axis and exerted synergistic compatibility.
    Dong B; Peng Y; Wang M; Peng C; Li X
    J Ethnopharmacol; 2024 May; 331():118276. PubMed ID: 38697408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
    Yao J; Jiao L; Yao Y; Lu Y; Shi J; Li J; Chen P; Xu L; Gong Y
    Trials; 2020 Apr; 21(1):309. PubMed ID: 32245480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer: A randomized, controlled trial.
    Xiao Z; Chen Z; Han R; Lu L; Li Z; Lin J; Hu L; Huang X; Lin L
    Medicine (Baltimore); 2021 May; 100(18):e25690. PubMed ID: 33950949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dachengqi decoction reduces inflammatory response and promotes recovery of gastrointestinal function in patients with mild acute pancreatitis by regulating the intestinal microbiota].
    Li J; Dai Y; Cao H; Xiao T; Ge B; Xing L; Yu X; Fu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Feb; 35(2):170-176. PubMed ID: 36916377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanism of Sijunzi decoction on improving intestinal injury with spleen deficiency syndrome and the rationality of its compatibility.
    Ma P; Peng C; Peng Y; Fan L; Chen X; Li X
    J Ethnopharmacol; 2023 Apr; 306():116088. PubMed ID: 36649851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study.
    Shoji F; Miura N; Tagawa T; Tsukamoto S; Okamoto T; Yamazaki K; Hamatake M; Takeo S
    Thorac Cancer; 2022 Oct; 13(19):2829-2833. PubMed ID: 36063818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Network Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Sijunzi Decoction Involved in Alleviating Airway Inflammation in a Mouse Model of Asthma.
    Jia W; Xu C; Zhao T; Fan Q; Qiao B; Wu Y; Yuan J; Chen J
    Evid Based Complement Alternat Med; 2023; 2023():1130893. PubMed ID: 36636604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 in treating patients of non-small cell lung cancer at peri-operational stage.
    Du QC; Yang KZ; Sun XF
    Chin J Integr Med; 2009 Jun; 15(3):184-8. PubMed ID: 19568710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sijunzi decoction enhances sensitivity of colon cancer cells to NK cell destruction by modulating P53 expression.
    Wang X; Pan S; Chen L; Liang C; Zhu Y; Zhou K; Shi X
    J Ethnopharmacol; 2024 Apr; 329():118115. PubMed ID: 38580190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of early intestinal application of sijunzi decoction on immune function in post-operational patients of gastrointestinal tumor].
    Liang C; Zhang SH; Cai ZD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1070-3. PubMed ID: 16398424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial.
    Bingula R; Filaire M; Radosevic-Robin N; Berthon JY; Bernalier-Donadille A; Vasson MP; Thivat E; Kwiatkowski F; Filaire E
    Medicine (Baltimore); 2018 Dec; 97(50):e13676. PubMed ID: 30558074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC.
    Jin Y; Dong H; Xia L; Yang Y; Zhu Y; Shen Y; Zheng H; Yao C; Wang Y; Lu S
    J Thorac Oncol; 2019 Aug; 14(8):1378-1389. PubMed ID: 31026576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the relationship between intestinal microbiota and immune checkpoint inhibitors in the treatment of non-small cell lung cancer: insights from the "lung and large intestine stand in exterior-interior relationship" theory.
    Li L; Zhong H; Wang Y; Pan Z; Xu S; Li S; Zeng G; Zhang W; Li J; He L
    Front Cell Infect Microbiol; 2024; 14():1341032. PubMed ID: 38415012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Si-jun-zi decoction treatment promotes the restoration of intestinal function after obstruction by regulating intestinal homeostasis.
    Yu X; Cui Z; Zhou Z; Shan T; Li D; Cui N
    Evid Based Complement Alternat Med; 2014; 2014():928579. PubMed ID: 24876882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.